All lobbying filings

ARENTFOX SCHIFF LLP

Lobbying for INFECTIOUS DISEASES SOCIETY OF AMERICA · Medical association promoting public health and prevention of infectious diseases

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $50,000.00 income · posted Apr 19, 2025

Official filing document

Bills named in this filing 3

HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
SCONRES 7
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal ye…
HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

Lobbying activity 3

Medical/Disease Research/Clinical Labs

Legislation related to anti-microbial resistence generally

Budget/Appropriations

Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for Infectious diseases programs FY 2025 funding for infectious diseases programs generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.

Medicare/Medicaid

Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2026 Physician Fee Schedule

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.